诱导β-上腺激素抗体的乳酸:一个案例报告
1Raymond R. Blush III is Clinical Assistant Professor, University of Michigan School of Nursing, Room 2304, 400 SNB N Ingalls, Ann Arbor, MI 48109 (rayblush@umich.edu).
AACN advanced critical care
|August 30, 2024
概括
阿尔布醇是一种常见的喘药物,即使患者在临床上有所改善,也可能导致乳酸盐水平升高和酸化. 这一案例凸显了在针对严重喘恶化症的强化阿尔布特罗尔治疗期间需要监测乳酸水平的必要性.
科学领域:
- 紧急医疗 紧急医疗
- 药理学 药理学是指药理学的学科.
- 关键的护理关键的护理
背景情况:
- 阿尔布醇是急性喘恶化的主要治疗方法.
- 严重的病例往往涉及连续的,高剂量阿尔布特罗尔的管理.
- 超乳糖血症和酸有多种原因导致急性呼吸不良.
研究的目的:
- 报告一个因服用阿尔布特罗尔而导致乳酸盐水平升高的病例.
- 讨论喘患者高乳糖血症的潜在原因.
- 概述阿尔布特罗尔诱导的高乳糖血症的监测和管理方面的考虑.
主要方法:
- 临床病例报告的呈现.
- 审查乳糖水平升高的潜在原因.
- 关于β-上腺素激动剂作用的讨论.
主要成果:
- 一名接受喘强化阿尔布托罗尔治疗的患者显示乳酸水平上升.
- 尽管临床上呼吸状况有所改善,但乳酸盐水平仍然增加.
- 艾布托罗尔的使用被确定为可能导致高乳糖血症的潜在原因.
结论:
- 阿尔布特罗尔可能是超乳糖血症和酸性病的未被认可的原因.
- 监测乳酸水平在接受强化阿尔布特罗尔的患者中至关重要.
- 如果乳酸水平显著上升,可能需要考虑停止使用阿尔布特罗尔.
相关概念视频
Adrenergic Antagonists: ɑ and β-Receptor Blockers
421
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
421
Hypoglycemia and Glucagon
217
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
217
Muscle Recovery and Fatigue
2.0K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
2.0K
Adrenergic Receptors: β Subtype
1.6K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.6K
Antiasthma Drugs: β2-Adrenoceptor Agonists
239
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
239
Insulin: Dosing Regimen and Adverse Effects
160
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
160


